Consolidated Statement of Cash Flows (Unaudited) $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)
Operating activities
Net increase/(decrease) in net assets resulting from operations	$ 1,392
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized gain (loss) on investments	(184)
Net change in unrealized gain (loss) on investments	(447)
Payments to purchase investments	(87,578)
Proceeds from sale of investments	11,381
Net (increase) decrease on derivatives	(5,522)
Changes in operating assets and liabilities:
(Increase)/decrease due from Operating Manager	(3,447)
(Increase)/decrease deferred offering expenses	(1,544)
(Increase)/decrease interest receivable	(560)
(Increase)/decrease prepaid expenses and other assets	(957)
Increase/(decrease) due to Operating Manager	5,227
Increase/(decrease) payable for investments purchased	3,435
Increase/(decrease) organizational expenses payable	(564)
Increase/(decrease) management fees payable	58
Increase/(decrease) interest payable	34
Increase/(decrease) performance fees payable	28
Increase/(decrease) in offering expenses payable	(677)
Increase/(decrease) other accrued expenses and liabilities	1,136
Net cash used in operating activities	(78,789)
Financing activities
Notes Borrowings	1,072
Proceeds from issuance of shares	90,770
Net cash provided by financing activities	91,842
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	13,053
Cash and cash equivalents at beginning of period	2
Cash and cash equivalents at end of period	13,055
Series I
Operating activities
Net increase/(decrease) in net assets resulting from operations	157
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized gain (loss) on investments	(29)
Net change in unrealized gain (loss) on investments	(53)
Payments to purchase investments	(14,072)
Proceeds from sale of investments	1,826
Net (increase) decrease on derivatives	(886)
Changes in operating assets and liabilities:
(Increase)/decrease due from Operating Manager	(340)
(Increase)/decrease deferred offering expenses	211
(Increase)/decrease interest receivable	(90)
(Increase)/decrease prepaid expenses and other assets	(215)
Increase/(decrease) due to Operating Manager	839
Increase/(decrease) payable for investments purchased	551
Increase/(decrease) organizational expenses payable	(304)
Increase/(decrease) management fees payable	23
Increase/(decrease) interest payable	17
Increase/(decrease) performance fees payable	10
Increase/(decrease) in offering expenses payable	(567)
Increase/(decrease) other accrued expenses and liabilities	190
Net cash used in operating activities	(12,732)
Financing activities
Notes Borrowings	536
Proceeds from issuance of shares	14,600
Net cash provided by financing activities	15,136
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	2,404
Cash and cash equivalents at beginning of period	1
Cash and cash equivalents at end of period	2,405
Series II
Operating activities
Net increase/(decrease) in net assets resulting from operations	1,235
Adjustments to reconcile net increase/(decrease) in net assets resulting from operations to net cash used in operating activities:
Net realized gain (loss) on investments	(155)
Net change in unrealized gain (loss) on investments	(394)
Payments to purchase investments	(73,506)
Proceeds from sale of investments	9,555
Net (increase) decrease on derivatives	(4,636)
Changes in operating assets and liabilities:
(Increase)/decrease due from Operating Manager	(3,107)
(Increase)/decrease deferred offering expenses	(1,755)
(Increase)/decrease interest receivable	(470)
(Increase)/decrease prepaid expenses and other assets	(742)
Increase/(decrease) due to Operating Manager	4,388
Increase/(decrease) payable for investments purchased	2,884
Increase/(decrease) organizational expenses payable	(260)
Increase/(decrease) management fees payable	35
Increase/(decrease) interest payable	17
Increase/(decrease) performance fees payable	18
Increase/(decrease) in offering expenses payable	(110)
Increase/(decrease) other accrued expenses and liabilities	946
Net cash used in operating activities	(66,057)
Financing activities
Notes Borrowings	536
Proceeds from issuance of shares	76,170
Net cash provided by financing activities	76,706
Cash and cash equivalents
Net increase/(decrease) in cash and cash equivalents	10,649
Cash and cash equivalents at beginning of period	1
Cash and cash equivalents at end of period	$ 10,650